Your browser doesn't support javascript.
loading
DNA-PKcs inhibitors sensitize neuroendocrine tumor cells to peptide receptor radionuclide therapy in vitro and in vivo.
Reuvers, Thom G A; Verkaik, Nicole S; Stuurman, Debra; de Ridder, Corrina; Groningen, Marian C Clahsen-van; de Blois, Erik; Nonnekens, Julie.
Affiliation
  • Reuvers TGA; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands.
  • Verkaik NS; Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands.
  • Stuurman D; Department of Molecular Genetics, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands.
  • de Ridder C; Department of Radiology and Nuclear Medicine, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands.
  • Groningen MCC; Department of Urology, Erasmus University Medical Center Rotterdam, The Netherlands.
  • de Blois E; Department of Urology, Erasmus University Medical Center Rotterdam, The Netherlands.
  • Nonnekens J; Department of Pathology, Erasmus University Medical Center Rotterdam, The Netherlands.
Theranostics ; 13(10): 3117-3130, 2023.
Article de En | MEDLINE | ID: mdl-37351169

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs neuroendocrines Type d'étude: Prognostic_studies Aspects: Patient_preference Limites: Animals / Humans Langue: En Journal: Theranostics Année: 2023 Type de document: Article Pays d'affiliation: Pays-Bas

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs neuroendocrines Type d'étude: Prognostic_studies Aspects: Patient_preference Limites: Animals / Humans Langue: En Journal: Theranostics Année: 2023 Type de document: Article Pays d'affiliation: Pays-Bas